Lannett Co Inc (LCI)
(Delayed Data from NYSE)
$8.54 USD
+0.70 (8.93%)
Updated May 3, 2019 04:00 PM ET
After-Market: $8.54 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[LCI]
Reports for Purchase
Showing records 381 - 400 ( 421 total )
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Levo Pricing Upside Drives Higher EPS Forecasts; PT to $23.50
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
FY4Q13 Recap - Trends Remain Positive - Upping #''s and PT
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Industry: Medical - Drugs
We are transferring coverage as a result of reorganization of our coverage universe
Provider: STONEGATE CAPITAL MARKETS
Industry: Medical - Drugs
Beating expectations while Company prepares for C-Topical expansion
Provider: STONEGATE CAPITAL MARKETS
Analyst: RODRIGUEZ M
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
FY3Q13 Preannounced Upside - Levo Likely the Driver
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
Q412 Results Miss Expectations But New Business Points in the Right Direction
Provider: STONEGATE CAPITAL MARKETS
Analyst: RODRIGUEZ M
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Industry: Medical - Drugs
Company Revenue from Cardiovascular medicines continue to make our heart race Q2FY13 results beat our modeled numbers
Provider: STONEGATE CAPITAL MARKETS
Analyst: RODRIGUEZ M
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
1Q13 Update - Reiterate Buy on Revenue Strength
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
We are transferring coverage of LCI to Marco Rodriguez as the previous analyst is no longer with the firm.
Provider: STONEGATE CAPITAL MARKETS